Presentation to Highlight the Company's Gene Therapies for Cancer and DiabetesAUSTIN, Texas, Sept. 3, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the Company's participation in the following upcoming investor and industry conferences to be held in September 2024.Event: H.C. Wainwright 26th Annual Global Investment ConferenceConference ...